| Symbol | AKOBF |
|---|---|
| Name | AKOBO MINERALS AB |
| Sector | UNDEFINED |
| Region | Europe |
| Industry | - |
| Address | VG 413 01 Sweden Södra Allégatan 13 |
| Telephone | +47 92 80 40 14 |
| Fax | — |
| — | |
| Website | https://akobominerals.com/ |
| Incorporation | SE |
| Incorporated On | 2018 |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | Frejs Revisions Byra AB; |
| Audit Status | AUDITED |
| Reporting Status | International Reporting: Oslo Bors |
| CIK | — |
| Description | Akobo Minerals is a Scandinavian-based gold exploration and boutique mining company, currently holding an exploration license covering 182 km2 and a mining license covering 16 km2 in the Gambela region and Dima Woreda, Ethiopia. The company has established itself as the leading gold exploration company in Ethiopia through more than 14 years of on-the-ground activity, which has now been enhanced further with the development of its Segele mine. Akobo Minerals Segele mine has an Inferred and Indicated Mineral Resource of 68,000 ounces, yielding a world-class gold grade of 22.7 g/ton. Still open to depth, the gold mineralised zone continues to expand and will have a positive impact on future resource estimates and the life expectancy of the mine. The exploration license holds numerous promising exploration resource-building prospects in both the vicinity of Segele and in the wider license area. Akobo Minerals has an excellent relationship with local communities all the way up to national authorities and the company places environment and social governance (ESG) at the heart of its activities - as demonstrated by a planned, industry-leading, extended shared value program. Akobo Minerals has built a strong local foothold based on the principles of sound ethics, transparency and communication, and is ready to take on new opportunities and ventures as they arise. The company is uniquely positioned to become a major player in the development of the promising Ethiopian mining sector. Additional info from OTC: |
No news found.